| Assessment Status | Awaiting Applicant submission |
| HTA ID | - |
| Drug | Emtricitabine / tenofovir disoproxil fumarate |
| Brand | Truvada® |
| Indication | In combination with safer sex practices for pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults at high risk. |
| Assessment Process | |
| Rapid review commissioned | 12/06/2017 |
| Rapid review completed | 18/07/2017 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
| Full pharmacoeconomic assessment commissioned by HSE | 19/07/2017 |
